ArticleTargeted oncology2021

Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies.

Alexander Spira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.